Rangan GK - Search Results

1

Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease.

Ta MH, Schwensen KG, Foster S, Korgaonkar M, Ozimek-Kulik JE, Phillips JK, Peduto A, Rangan GK. Ta MH, et al. Among authors: rangan gk. PLoS One. 2016 Oct 10;11(10):e0164193. doi: 10.1371/journal.pone.0164193. eCollection 2016. PLoS One. 2016. PMID: 27723777 Free PMC article.

2

Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease.

Phillips JK, Hopwood D, Loxley RA, Ghatora K, Coombes JD, Tan YS, Harrison JL, McKitrick DJ, Holobotvskyy V, Arnolda LF, Rangan GK. Phillips JK, et al. Among authors: rangan gk. Kidney Blood Press Res. 2007;30(3):129-44. doi: 10.1159/000101828. Epub 2007 Apr 19. Kidney Blood Press Res. 2007. PMID: 17446713

3

Therapeutic role of sirolimus in non-transplant kidney disease.

Rangan GK, Nguyen T, Mainra R, Succar L, Schwensen KG, Burgess JS, Ho KO. Rangan GK, et al. Pharmacol Ther. 2009 Aug;123(2):187-206. doi: 10.1016/j.pharmthera.2009.03.014. Epub 2009 Apr 15. Pharmacol Ther. 2009. PMID: 19374918 Review.

4

Early cyst growth is associated with the increased nuclear expression of cyclin D1/Rb protein in an autosomal-recessive polycystic kidney disease rat model.

Schwensen KG, Burgess JS, Graf NS, Alexander SI, Harris DC, Phillips JK, Rangan GK. Schwensen KG, et al. Among authors: rangan gk. Nephron Exp Nephrol. 2011;117(4):e93-103. doi: 10.1159/000320149. Epub 2010 Oct 2. Nephron Exp Nephrol. 2011. PMID: 20924203

5

Role of interstitial inflammation in the pathogenesis of polycystic kidney disease.

Ta MH, Harris DC, Rangan GK. Ta MH, et al. Among authors: rangan gk. Nephrology (Carlton). 2013 May;18(5):317-30. doi: 10.1111/nep.12045. Nephrology (Carlton). 2013. PMID: 23448509 Review.

6

Chronic effects of dietary vitamin D deficiency without increased calcium supplementation on the progression of experimental polycystic kidney disease.

Rangan GK, Schwensen KG, Foster SL, Korgaonkar MS, Peduto A, Harris DC. Rangan GK, et al. Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F574-82. doi: 10.1152/ajprenal.00411.2012. Epub 2013 May 22. Am J Physiol Renal Physiol. 2013. PMID: 23698116 Free article.

7

Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease.

Ta MH, Rao P, Korgaonkar M, Foster SF, Peduto A, Harris DC, Rangan GK. Ta MH, et al. Among authors: rangan gk. Physiol Rep. 2014 Dec 11;2(12):e12196. doi: 10.14814/phy2.12196. Print 2014 Dec 1. Physiol Rep. 2014. PMID: 25501440 Free PMC article.

8

Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells.

Ta MH, Liuwantara D, Rangan GK. Ta MH, et al. Among authors: rangan gk. BMC Nephrol. 2015 Dec 15;16:212. doi: 10.1186/s12882-015-0193-3. BMC Nephrol. 2015. PMID: 26666710 Free PMC article.

9

KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Pharmacological Management.

Mallett A, Lee VW, Mai J, Lopez-Vargas P, Rangan GK. Mallett A, et al. Among authors: rangan gk. Semin Nephrol. 2015 Nov;35(6):582-589.e17. doi: 10.1016/j.semnephrol.2015.10.009. Semin Nephrol. 2015. PMID: 26718162 Review. No abstract available.

10

Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats.

Ta MH, Schwensen KG, Liuwantara D, Huso DL, Watnick T, Rangan GK. Ta MH, et al. Among authors: rangan gk. World J Nephrol. 2016 Jul 6;5(4):339-57. doi: 10.5527/wjn.v5.i4.339. World J Nephrol. 2016. PMID: 27458563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page